Avak Kahvejian
Oprichter bij Cygnal Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Avak Kahvejian
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
214
| Private Company | Investment Managers | 214 |
| Private Company | Biotechnology | 25 | |
| Extinct | Miscellaneous Commercial Services | 21 | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA.
13
| Holding Company | Biotechnology | 13 |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018.
13
| Holding Company | Biotechnology | 13 |
International Institute of New England, Inc.
 International Institute of New England, Inc. Services to the Health IndustryHealth Services International Institute of New England, Inc. operates as a non-profit organization serving immigrants, refugees, asylees, and other vulnerable populations. Its services include refugee resettlement, case management, health services navigation, employment, education and literacy and citizenship programming. The company was founded in 1910 and is headquartered in Boston, MA.
12
| Non-Profit Organization | Services to the Health Industry | 12 |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA.
5
| Subsidiary | Biotechnology | 5 |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023.
4
| Holding Company | Biotechnology | 4 |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then.
3
| Holding Company | Pharmaceuticals: Other | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Avak Kahvejian via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Director/Board Member Director of Finance/CFO Chairman Founder Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO Director of Finance/CFO Chairman Chief Tech/Sci/R&D Officer | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer Founder | |
| University of Wisconsin | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member Founder Chief Operating Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal | |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Founder Director/Board Member | |
Invaio Sciences, Inc.
 Invaio Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Invaio Sciences, Inc. operates as multi-platform technology company. The firm develops multi-platform technology company that unlocks the potential of planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges. The company was founded in 2018 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer Founder Founder | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder Chairman | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member President | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Founder | |
| McGill University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder President | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
Affinnova, Inc.
 Affinnova, Inc. Information Technology ServicesTechnology Services Affinnova, Inc. is a global marketing technology, which provides sales solutions for large and mid-sized enterprises. The company was founded by Kamal M. Malek in 2000 and is headquartered in New York, NY. | Information Technology Services | Founder Director of Finance/CFO | |
| Washington University in St. Louis | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree | |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| Harvard Mit Health Sciences & Technology | College/University | Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Founder |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Verenigd Koninkrijk | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Technology Services | 4 |
| Finance | 2 |
Operationeel
| Director/Board Member | 265 |
| Corporate Officer/Principal | 128 |
| Founder | 89 |
| Undergraduate Degree | 70 |
| Private Equity Investor | 70 |
Sterkste connecties
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Ed Kania | 31 |
| Michael Rosenblatt | 31 |
| David Epstein | 29 |
| Theo Melas-Kyriazi | 26 |
| James Collins | 25 |
| Pablo Cagnoni | 24 |
| Stéphane Bancel | 23 |
| Ignacio Martinez | 21 |
| James Gilbert | 20 |
| Geoffrey von Maltzahn | 15 |
| Diego Miralles | 14 |
| Rupert Vessey | 13 |
| Pearl Shirley Huang | 13 |
| Jonathan Ian Schwartz | 13 |
- Beurs
- Insiders
- Avak Kahvejian
- Bedrijfsconnecties
